NCT01627275View on ClinicalTrials.gov

Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 24, 2017

Study Completion Date

August 3, 2017

Conditions
Hematological Malignancies
Interventions
BIOLOGICAL

Naive T Cell Depleted Donor Lymphocyte Infusion

A single naive T-cell depleted donor lymphocyte infusion will be administered through a peripheral or central venous catheter greater than or equal to 60 days post allogeneic hematopoietic stem cell transplant.

Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
lead

Mitchell Horwitz, MD

OTHER

NCT01627275 - Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant | Biotech Hunter | Biotech Hunter